143 related articles for article (PubMed ID: 36997217)
1. GPs' willingness to prescribe aspirin for cancer preventive therapy in Lynch syndrome: a factorial randomised trial investigating factors influencing decisions.
Lloyd KE; Hall LH; Ziegler L; Foy R; Borthwick GM; MacKenzie M; Taylor DG; Smith SG;
Br J Gen Pract; 2023 Apr; 73(729):e302-e309. PubMed ID: 36997217
[TBL] [Abstract][Full Text] [Related]
2. General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national survey.
Smith SG; Foy R; McGowan J; Kobayashi LC; Burn J; Brown K; Side L; Cuzick J
Fam Cancer; 2017 Oct; 16(4):509-516. PubMed ID: 28434157
[TBL] [Abstract][Full Text] [Related]
3. Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes.
Smith SG; Foy R; McGowan JA; Kobayashi LC; de Censi A; DeCensi A; Brown K; Side L; Cuzick J
Br J Gen Pract; 2017 Jun; 67(659):e414-e427. PubMed ID: 28193617
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providers.
Lloyd KE; Foy R; Hall LH; Ziegler L; Green SMC; Haider ZF; Taylor DG; MacKenzie M; Smith SG
Hered Cancer Clin Pract; 2022 Aug; 20(1):30. PubMed ID: 35999639
[TBL] [Abstract][Full Text] [Related]
5. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine.
Serrano D; Patrignani P; Stigliano V; Turchetti D; Sciallero S; Roviello F; D'Arpino A; Grattagliano I; Testa S; Oliani C; Bertario L; Bonanni B
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328014
[TBL] [Abstract][Full Text] [Related]
8. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
[TBL] [Abstract][Full Text] [Related]
9. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
Burn J; Mathers J; Bishop DT
Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention in Lynch syndrome.
Burn J; Mathers JC; Bishop DT
Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
[TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care.
Nguyen P; McIntosh J; Bickerstaffe A; Maddumarachchi S; Cummings KL; Emery JD
Br J Gen Pract; 2019 Dec; 69(689):e843-e849. PubMed ID: 31740461
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial).
Burn J; Mathers J; Bishop DT
Dig Dis; 2012; 30 Suppl 2():39-47. PubMed ID: 23207931
[TBL] [Abstract][Full Text] [Related]
14. Willingness of French General Practitioners to Prescribe mHealth Apps and Devices: Quantitative Study.
Della Vecchia C; Leroy T; Bauquier C; Pannard M; Sarradon-Eck A; Darmon D; Dufour JC; Preau M
JMIR Mhealth Uhealth; 2022 Feb; 10(2):e28372. PubMed ID: 35147508
[TBL] [Abstract][Full Text] [Related]
15. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
Short D; Frischer M; Bashford J; Ashcroft D
BMC Fam Pract; 2003 Jul; 4():9. PubMed ID: 12871601
[TBL] [Abstract][Full Text] [Related]
16. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study exploring how GPs decide to prescribe antidepressants.
Hyde J; Calnan M; Prior L; Lewis G; Kessler D; Sharp D
Br J Gen Pract; 2005 Oct; 55(519):755-62. PubMed ID: 16212850
[TBL] [Abstract][Full Text] [Related]
19. An RCT of a decision aid to support informed choices about taking aspirin to prevent colorectal cancer and other chronic diseases: a study protocol for the SITA (Should I Take Aspirin?) trial.
Milton S; McIntosh J; Macrae F; Chondros P; Trevena L; Jenkins M; Walter FM; Taylor N; Boyd L; Saya S; Karnchanachari N; Novy K; Forbes C; Gutierrez JM; Broun K; Whitburn S; McGill S; Fishman G; Marker J; Shub M; Emery J
Trials; 2021 Jul; 22(1):452. PubMed ID: 34266464
[TBL] [Abstract][Full Text] [Related]
20. The development and evaluation of a computerised decision support system for primary care based upon 'patient profile decision analysis'.
Short D; Frischer M; Bashford J
Inform Prim Care; 2003; 11(4):195-202. PubMed ID: 14980058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
